Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune Response

Staphylococcus aureus (S. aureus) was the most prevalent bacteria recorded from clinical and subclinical mastitis. The main objective of the present work is to prepare and evaluate the effectiveness of locally prepared inactivated S. aureus vaccine using different adjuvants Montanide ISA-206, Montan...

Full description

Bibliographic Details
Main Authors: Ebtsam E.Z. Kotb, Amal M. EL Sawah, Laila E. Kortam, Ola A. Abd El Fattah, Waleed M. Barghooth
Format: Article
Language:English
Published: Rabie Fayed 2021-01-01
Series:Journal of Applied Veterinary Sciences
Subjects:
Online Access:https://javs.journals.ekb.eg/article_140065.html
id doaj-28b3a279f19f4a02a55bd8c1da6ad8e4
record_format Article
spelling doaj-28b3a279f19f4a02a55bd8c1da6ad8e42021-03-28T18:19:13ZengRabie FayedJournal of Applied Veterinary Sciences1687-40722090-33082021-01-0161917https://dx.doi.org/10.21608/javs.2021.140065Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune ResponseEbtsam E.Z. Kotb0Amal M. EL Sawah1Laila E. Kortam2Ola A. Abd El Fattah3Waleed M. Barghooth4Animal Reproduction Research Institute (ARRI), Agricultural Research Center (ARC), Egypt.Central Laboratory for Evaluation of Veterinary Biologics , Agricultural Research Center (ARC), Egypt.Animal Reproduction Research Institute (ARRI), Agricultural Research Center (ARC), Egypt.Animal Health Research Institute (AHRI), Giza lab., Agricultural Research Center (ARC), Egypt.Central Laboratory for Evaluation of Veterinary Biologics , Agricultural Research Center (ARC), Egypt.Staphylococcus aureus (S. aureus) was the most prevalent bacteria recorded from clinical and subclinical mastitis. The main objective of the present work is to prepare and evaluate the effectiveness of locally prepared inactivated S. aureus vaccine using different adjuvants Montanide ISA-206, Montanide ISA-70 and alum hydroxide gel for detection of cellular and humeral immune responses. Seventy dairy heifers in the last trimester of gestation divided into (5) groups. Twenty pregnant cows in three groups (G1, G2, and G3) were inoculated intramuscularly with the prepared vaccines four weeks prior to calving then a booster dose at two weeks pre-expected calving. The animals in remaining groups (G4 and G5) were considered as control and safety test respectively. Serum samples from vaccinated and non-vaccinated cows were collected at the 1st and 2nd immunization then at 0, 1, 2, 3 months and (7, 10, 14) days post calving and vaccination and evaluated immunologically using ELISA and Lymphocyte transformation assay, respectively. The results revealed that a progressive increase of immune response in the vaccinated groups (G1 and G2) than that of the third and control groups. These results could be indicated the safety and effectiveness of the Montanide ISA-206, ISA-70 vaccines than alum adjuvant vaccine that reduce the incidence and severity of clinical cases of mastitis. Hence, further studies should be done to elucidate the possibility of field application.https://javs.journals.ekb.eg/article_140065.htmladjuvantmastitisstaphylococcus aureusvaccine
collection DOAJ
language English
format Article
sources DOAJ
author Ebtsam E.Z. Kotb
Amal M. EL Sawah
Laila E. Kortam
Ola A. Abd El Fattah
Waleed M. Barghooth
spellingShingle Ebtsam E.Z. Kotb
Amal M. EL Sawah
Laila E. Kortam
Ola A. Abd El Fattah
Waleed M. Barghooth
Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune Response
Journal of Applied Veterinary Sciences
adjuvant
mastitis
staphylococcus aureus
vaccine
author_facet Ebtsam E.Z. Kotb
Amal M. EL Sawah
Laila E. Kortam
Ola A. Abd El Fattah
Waleed M. Barghooth
author_sort Ebtsam E.Z. Kotb
title Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune Response
title_short Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune Response
title_full Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune Response
title_fullStr Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune Response
title_full_unstemmed Evaluation Of Using Different Adjuvants Used For Preparation Of Staphylococcus Aureus Mastitis Vaccine On The Immune Response
title_sort evaluation of using different adjuvants used for preparation of staphylococcus aureus mastitis vaccine on the immune response
publisher Rabie Fayed
series Journal of Applied Veterinary Sciences
issn 1687-4072
2090-3308
publishDate 2021-01-01
description Staphylococcus aureus (S. aureus) was the most prevalent bacteria recorded from clinical and subclinical mastitis. The main objective of the present work is to prepare and evaluate the effectiveness of locally prepared inactivated S. aureus vaccine using different adjuvants Montanide ISA-206, Montanide ISA-70 and alum hydroxide gel for detection of cellular and humeral immune responses. Seventy dairy heifers in the last trimester of gestation divided into (5) groups. Twenty pregnant cows in three groups (G1, G2, and G3) were inoculated intramuscularly with the prepared vaccines four weeks prior to calving then a booster dose at two weeks pre-expected calving. The animals in remaining groups (G4 and G5) were considered as control and safety test respectively. Serum samples from vaccinated and non-vaccinated cows were collected at the 1st and 2nd immunization then at 0, 1, 2, 3 months and (7, 10, 14) days post calving and vaccination and evaluated immunologically using ELISA and Lymphocyte transformation assay, respectively. The results revealed that a progressive increase of immune response in the vaccinated groups (G1 and G2) than that of the third and control groups. These results could be indicated the safety and effectiveness of the Montanide ISA-206, ISA-70 vaccines than alum adjuvant vaccine that reduce the incidence and severity of clinical cases of mastitis. Hence, further studies should be done to elucidate the possibility of field application.
topic adjuvant
mastitis
staphylococcus aureus
vaccine
url https://javs.journals.ekb.eg/article_140065.html
work_keys_str_mv AT ebtsamezkotb evaluationofusingdifferentadjuvantsusedforpreparationofstaphylococcusaureusmastitisvaccineontheimmuneresponse
AT amalmelsawah evaluationofusingdifferentadjuvantsusedforpreparationofstaphylococcusaureusmastitisvaccineontheimmuneresponse
AT lailaekortam evaluationofusingdifferentadjuvantsusedforpreparationofstaphylococcusaureusmastitisvaccineontheimmuneresponse
AT olaaabdelfattah evaluationofusingdifferentadjuvantsusedforpreparationofstaphylococcusaureusmastitisvaccineontheimmuneresponse
AT waleedmbarghooth evaluationofusingdifferentadjuvantsusedforpreparationofstaphylococcusaureusmastitisvaccineontheimmuneresponse
_version_ 1724199474838896640